Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of CMMB will rise by +25.61% over the next 2 Weeks and hit $3.38 by Wednesday, September 23, 2026. In that time frame, CMMB's share price is expected to range between $3.26 and $3.50.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Sep 24, 2026 | 3.07 | 3.21 | 3.33 |
| Sep 23, 2026 | 3.04 | 3.17 | 3.30 |
| Sep 22, 2026 | 2.90 | 3.03 | 3.17 |
| Sep 21, 2026 | 2.89 | 3.01 | 3.14 |
| Sep 18, 2026 | 2.84 | 2.96 | 3.09 |
| Sep 17, 2026 | 2.81 | 2.94 | 3.05 |
| Sep 16, 2026 | 2.76 | 2.89 | 3.02 |
| Sep 15, 2026 | 2.64 | 2.76 | 2.88 |
| Sep 14, 2026 | 2.62 | 2.74 | 2.86 |
| Sep 11, 2026 | 2.57 | 2.69 | 2.82 |
CMMB shares fell -3.35% in Thursday, September 10, 2026's trading session, dropping from a previous close of $2.69 to move at $2.60. The stock demonstrated notable intraday movement (see CMMB's key stats for a full breakdown), fluctuating between $2.59 and $2.70, a +4.24% trading range. While recent weeks have seen some volatility, CMMB has managed to secure a -4.41% drop over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 23.79K shares changing hands, 52.8K fewer than the previous session. This amounted to $61.85K in total market activity.
Will CMMB Continue Its Upward Trend?
According to analyst ratings and projections for CMMB, Chemomab Therapeutics Ltd. shares are anticipated to increase by +21.87%, potentially reaching $3.33 per share by September 24, 2026. Short-term technical indicators for CMMB currently suggest a bullish sentiment. This aligns with the stock's recent performance, as it has recorded 21 positive trading days within the past 30 sessions. Based on the CMMB stock forecast, now is a good time to buy CMMB stock because its current trading price is -18.97% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on CMMB covering social and institutional perspectives.
CMMB Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into CMMB's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 58.96% to 64.60%) suggest the stock is showing bullish momentum with some volatility. The 50-day RSI, at 58.43%, suggests a neutral medium-term outlook. However, the 100-day RSI, at 52.63%, maintains a neutral outlook for the long term. Insights into CMMB's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Chemomab Therapeutics Short-Term Forecasts
CMMB Forecast For Next 5 Days
Our algorithm anticipates Chemomab Therapeutics (CMMB) stock could hit $2.61 by Sep 17, 2026. This represents a +0.22% fall from today's price, following a -13.66% change over the past five days.
CMMB Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Chemomab Therapeutics Ltd. (CMMB) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $2.84, which would mean a +9.23% increase from the current price of $2.60. Projections for this period range from a high of $3.77 to a low of $2.11.
CMMB Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Chemomab Therapeutics's price over the next three months point to a rise. CMMB stock is expected to peak at $8.63 on Sep 21, 2026 before potentially dipping to $5.72 on Nov 06, 2026. On average, CMMB is likely to trade around $6.91 in the coming 90 days.
Chemomab Therapeutics Stock Forecast 2025
Based on our predictive models, Chemomab Therapeutics (CMMB) is expected to trade between $5.53 and $8.63 throughout 2026. This would result in an average price of $6.83, potentially offering investors a +162.69% return from current levels.
Chemomab Therapeutics Ltd. Monthly Forecast 2026–2027
September 2026
According to our latest forecast models, Chemomab Therapeutics Ltd. (CMMB) is positioned to show a strong performance in September 2026. The price is predicted to move between $7.33 and $8.63, settling at an average of $8.19. This could translate to a +215.00% gain.
October 2026
Based on current market signals, Chemomab Therapeutics Ltd. is projected to trend october 2026. We forecast a trading range from $5.88 to $7.44, with a likely average price of $6.71. Investors could expect a potential return of +158.08%.
November 2026
Our predictive algorithms indicate Chemomab Therapeutics Ltd. stock may see a shift in November 2026. The expected range spans $5.72–$7.10, with an average target of $6.40. This represents a positive outlook and a possible gain of +146.15%.
December 2026
Analyzing established trends, Chemomab Therapeutics Ltd. looks set to move in December 2026. Projections place the stock between $5.53 and $7.54, averaging around $6.51. This suggests a +150.38% gain from current levels.
January 2027
Market indicators suggest Chemomab Therapeutics Ltd. could experience notable changes during January 2027. Prices could fluctuate within $6.03 to $8.25, with a midpoint forecast of $7.55. The stock might deliver a +190.38% gain.
February 2027
Forecasting for February 2027, models estimate that Chemomab Therapeutics Ltd. may undergo key fluctuations. If trends hold, the stock might trade between $5.95 and $8.99, averaging $7.95. This signals a positive trajectory with potential returns around +205.77%.
March 2027
According to our latest forecast models, Chemomab Therapeutics Ltd. (CMMB) is positioned to show a strong performance in March 2027. The price is predicted to move between $3.78 and $7.91, settling at an average of $6.60. This could translate to a +153.85% gain.
April 2027
Based on current market signals, Chemomab Therapeutics Ltd. is projected to trend april 2027. We forecast a trading range from $3.51 to $6.90, with a likely average price of $5.58. Investors could expect a potential return of +114.62%.
May 2027
Our predictive algorithms indicate Chemomab Therapeutics Ltd. stock may see a shift in May 2027. The expected range spans $3.76–$8.29, with an average target of $6.90. This represents a positive outlook and a possible gain of +165.38%.
June 2027
Analyzing established trends, Chemomab Therapeutics Ltd. looks set to move in June 2027. Projections place the stock between $2.85 and $8.61, averaging around $7.46. This suggests a +186.92% gain from current levels.
July 2027
Market indicators suggest Chemomab Therapeutics Ltd. could experience notable changes during July 2027. Prices could fluctuate within $2.77 to $10.34, with a midpoint forecast of $8.46. The stock might deliver a +225.38% gain.
August 2027
Forecasting for August 2027, models estimate that Chemomab Therapeutics Ltd. may undergo key fluctuations. If trends hold, the stock might trade between $1.83 and $8.63, averaging $7.32. This signals a positive trajectory with potential returns around +181.54%.
September 2027
According to our latest forecast models, Chemomab Therapeutics Ltd. (CMMB) is positioned to show a strong performance in September 2027. The price is predicted to move between $1.71 and $9.49, settling at an average of $8.32. This could translate to a +220.00% gain.
CMMB's history of dividends and stock splits also plays a role in long-term investor confidence.